Cubist Systematic Strategies’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-108
Closed -$5K 3293
2021
Q2
$5K Sell
108
-191
-64% -$8.39K ﹤0.01% 2878
2021
Q1
$14K Sell
299
-1,419
-83% -$82.6K ﹤0.01% 2779
2020
Q4
$169K Buy
1,718
+1,530
+814% +$134K ﹤0.01% 2303
2020
Q3
$13K Sell
188
-25
-12% -$2.18K ﹤0.01% 2425
2020
Q2
$22K Buy
+213
New +$25.3K ﹤0.01% 2315
2020
Q1
Sell
-234
Closed -$27K 2581
2019
Q4
$27K Sell
234
-510
-69% -$38.4K ﹤0.01% 2322
2019
Q3
$46K Sell
744
-314
-30% -$25.1K ﹤0.01% 2058
2019
Q2
$82K Buy
+1,058
New +$120K ﹤0.01% 2270
2018
Q3
Sell
-504
Closed -$50K 2162
2018
Q2
$50K Sell
504
-1,116
-69% -$126K ﹤0.01% 1644
2018
Q1
$204K Sell
1,620
-55
-3% -$8.58K 0.01% 1390
2017
Q4
$280K Buy
+1,675
New +$429K 0.01% 1300
2017
Q3
Sell
-749
Closed -$222K 2060
2017
Q2
$222K Buy
749
+74
+11% +$19.8K 0.01% 1229
2017
Q1
$156K Buy
+675
New +$117K 0.01% 1275
2015
Q2
Sell
-101
Closed -$33K 2116
2015
Q1
$33K Buy
+101
New +$35.9K ﹤0.01% 1796

Other funds holding CALA

Cubist Systematic Strategies's CALA Position: Q3 2021 in Review

Cubist Systematic Strategies sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 108 shares — an estimated $5K sold.

Cubist Systematic Strategies first reported a position in CALA in Q1 2015 and held it in 14 quarters. The position peaked at $280K in Q4 2017. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • Cubist Systematic Strategies reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 108 Calithera Biosciences, Inc shares in Q3 2021, an estimated $5K.
  • Cubist Systematic Strategies first reported a position in Calithera Biosciences, Inc in Q1 2015 and held it in 14 quarters.
  • Cubist Systematic Strategies's Calithera Biosciences, Inc position peaked at $280K in Q4 2017.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Cubist Systematic Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.